08:59 AM EDT, 05/08/2024 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) , a Canadian dermatology company, on Wednesday reported a first-quarter net loss of $626,000, or $0.03 per share, wider than a loss of $273,000, or $0.01 per share, a year earlier.

Revenue for the quarter ended March 31 was $5 million, up from $4.6 million a year earlier.

The increase in revenue was mainly driven by incremental revenue of $372,000 in the company's manufacturing segment.

The adjusted EBITDA loss for Q1 was $325,000, as compared with adjusted EBITDA of $161,000 a year earlier.